MOR GEORGE ADI

PrivateCIK: 1851069
Location

TEL AVIV, L3

MOR GEORGE ADI (Chief Executive Officer) sold 5.2% of their position (13.80K shares) of CHEMOMAB THERAPEUTICS LTD. on the open market

Open‑market sale worth $69.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 2 sales
InsiderMOR GEORGE ADICIK 1851069
DirectorOfficer10% Owner· Chief Executive Officer
Since Mar 2021
+151.62K
Net shares
Net buyer
$69.4K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
165.42K acquired · 13.80K disposed
Non-Derivative Transactions2

American Depositary Shares

Direct
S · Sale

Shares

7.70K

Price / share

$5.03

Trade value

$38.71K

% of position

2.4%
1/3/2023
324.77K317.07K

American Depositary Shares

Indirect
S · Sale

Shares

6.10K

Price / share

$5.03

Trade value

$30.66K

% of position

2.4%
1/3/2023
257.25K251.15K
Total

Net shares

13.80K

Net value

-$69.37K

Derivative Transactions2

Option to Purchase American Depositary Shares

Indirect
A · Award
Converts to

American Depositary Shares

33.73K shares

Shares

+33.73K

Strike price

0.8

Held after

33.73K

Exercisable

10/28/2016

Option to Purchase American Depositary Shares

Direct
A · Award
Converts to

American Depositary Shares

131.70K shares

Shares

+131.70K

Strike price

1.49

Held after

131.70K

Exercisable

3/15/2018
MOR GEORGE ADI — Insider Transaction (Form 4) Filed Jan 5, 2023 | Finecho